CYNTHIA EVANS: Open Payments
NPI 1235371766 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 21 payments from 11 companies in 2025. Trend: 2023 $790 · 2024 $407 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Apellis Pharmaceuticals, Inc. | 2 | $54 |
| Recor Medical Inc | 1 | $31 |
| Calliditas Therapeutics US Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Travere Therapeutics, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Fresenius USA Marketing, Inc. | 1 | $20 |
Products named: TAVNEOS, JYNARQUE, Paradise Ultrasound Renal Denervation System, Vanrafia, VOYXACT, TARPEYO, FUROSCIX, Empaveli.
Industry payments across SC — which companies pay providers there.
